Asthma Benefits

Asthma is a lung disease characterized by variable and reversible airway obstruction, airway inflammation, and bronchial hyper-responsiveness. Causes recurring periods of wheezing, shortness of breath, chest tightness, and coughing; coughing normally occurs at night or early morning. Asthma affects people of all ages and mostly starts in childhood. In the United States, more than twenty-five million people are diagnosed with asthma and about seven million of these people are children.

About one in 15 people has asthma and it still continues to grow each day. Asthma is a

Asthma health tips are important; people can be diagnosed with asthma symptoms at a very early age. Of course, victims of asthma generally complain about how annoying and sporadic attacks can be while out in the real world. Additionally, most assume that there lungs are perfect enough to not be bothered. However, everyday living--with asthma related symptoms--proves that owning irritated lungs is a common and detrimental experience for the unexpected ones.

According to the CDC and the EPA, an average of 23 million of people in the US have asthma with 6 million children included with a high prevalence among children younger than 18 year old. African Americans and Hispanics particularly Puerto Ricans, have a higher rate of asthma compare to the Caucasian population. Women are more likely than men susceptible to asthma. The estimated yearly cost of asthma is $56 billion in medication, hospital care as well as loss of school and work days. From 2002 to 2012, asthma has become one of the top five most costly conditions in the US based on a report from the Medical Expenditure Panel Survey (MEPS) (Soni, 2015).

In the world of pharmaceuticals, “there is a continuing interest in developing once-daily medications to further simplify treatment regimens and improve patient compliance”, especially when treating COPD and Asthma 1. “Suitable therapies for asthma and COPD need to provide targeted, long lasting and consistent efficacy” 2. This research paper summarizes the current clinical findings of a new drug called Abediterol a LABA. In addition to this, we will also summarize the most current research on abediterol versus the current SABA’s albuterol, and LABA’s salmeterol, indacaterol, olodaterol, and vilanterol in its treatment of asthma. Abediterol is a promising new potent LABA, currently in Phase II development. This is a drug that is used as a once daily treatment for chronic obstructive pulmonary disease COPD and asthma in combination with an Inhaled Corticosteroids ICS 3.

Asthma, also called bronchial asthma, is a condition in which a person’s airways become inflamed, narrow, and swell, and produce extra mucus, which makes it difficult to breathe. It is a very common condition with more than 3 million U.S. cases per year. Asthma is a chronic condition than can last either a few years or it could be lifelong. It is unclear why some people get asthma and others don’t, but it is probably due to a combination of environmental and genetic factors. An asthma attack is brought on by triggers and the triggers vary from person to person. I know for myself animal dander, dust; pollen, mold, and fresh cut grass are triggers. Physical activity, air pollutants, certain foods, and certain medications are just a few more things

Asthma is a long-term medical condition that affects the airways. When a person has asthma the walls of the air tubes that transport the air in and out of the lungs become irritated and swollen. In this condition, the air tubes get smaller and the cells produce more mucus than usual clogging the air tubes and preventing the air to reach the lungs. This disease makes the airways very sensitive, in consequence they may be greatly affected by any allergic reaction a person may have. Asthma affects people of all ages, there is an average of 25 million people affected by this condition in the united states. People that have a family history with asthma and allergies are more likely to have this condition.

In this paper I will be discussing the effects of respiratory acidosis on the body. More specifically, I will be discussing these effects in the relation to Asthma. I will describe the anatomical changes and pathophysiology of the disease, explain how it effects elimination of carbon dioxide from the airway, state the physiological compensation mechanisms and relate this condition back to respiratory acidosis and its effect on the body.

Asthma is a common respiratory disorder that is mediated by T helper type 2 (TH2) cytokine production, leading to airflow obstruction and airway hyper-responsiveness. Infant infection of human respiratory syncytial virus (RSV) has been shown to be the greatest risk factor for developing asthma. Interferon regulatory factor 7 (IRF7), activated by TLR7 in pDCs, is a crucial regulator of type I interferon (IFN) in the antiviral response. This paper provides preliminary data to show that IL-13 levels are significantly increased in IRF7

Asthma is known as a chronic respiratory disease that affects the lungs. According with the Centers for Disease Control and Prevention (CDC), estimated asthma incidence in the United States is 3.8/1000 in adults and 12.5/1000 in children. Prevalence rate of asthma in the United States increased from 7.3% in 2001 to 8.4% in 2010. Based on the statistics in the United States, it is more common that children have asthma than adults, especially women than men. Comparing with Texas, the estimated prevalence rate of asthma is an estimated of 6.8% of adults (1,296, 000 adults).

Asthma is among the diseases that have shown a significant increase in prevalence in recent attacks of wheezing. Asthma is a chronic condition characterized by periodic attacks of wheezing, coughing and shortness of breath. More than 7 million US children suffer from it and worldwide it’s nearly 150 million. Asthma constrict the airways that lead to the lungs and partially block the passage for air to pass through.

Asthma is a chronic disorder of the respiratory system that involves airway obstruction, bronchial hyper responsiveness and inflammation of airways that is commonly caused by allergens or other forms of sensitivity. The causes of asthma are not fully understood but the underlying factors that contribute to the onset of it have been confirmed. Genetic factors along with exposure to environmental factors such as inhalable substances or particles may inhibit the onset of an allergic reaction or irritate the airways causing an episode of asthma. Common irritants that contribute to an asthma attack include;

Asthma is often thought of as a childhood disease. However, asthma can affect all ages, young, old, and everyone in between. According to Kathleen Scogna, in her article, Asthma in The Gale Encyclopedia of Science, “there are approximately 7 million people 18 years of age or younger and 17.8 million adults have asthma in the United States” (Scogna 2014). Asthma can be genetic, as is often the case when diagnosed in children however, it can also present later in life. Asthma is a chronic inflammatory disease that causes the narrowing of the airways, which prevents oxygen reaching the alveoli: the air sac in the lungs. As a result, the body begins to burn oxygen much faster than usual. Asthma is frequently known to produce bouts of coughing, wheezing, and breathlessness. Although asthma responds well to treatment, it can be a wearisome disease. Common triggers for asthma include cold air, exercise, dust mites, air pollution, stress and anxiety.

The lung cancer treatment plan is selected by the patient as well as the doctor, based upon a number of factors, such as the overall health, type and stage of cancer, and the patient’s preferences. The options typically include one treatment and in some cases more treatments, including surgery, chemotherapy, radiation therapy or targeted drug therapy.

Airways are tubes that carry air in and out of one’s lungs. These airways become swollen because of Asthma, making less air flow inside the body.